Literature DB >> 2014984

Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae.

F Bellido1, J C Pechère, R E Hancock.   

Abstract

The roles of outer membrane permeability, beta-lactamase stability, and inhibition of penicillin-binding proteins in the activity of new beta-lactams against Enterobacter cloacae were reappraised by using several methodological improvements. Outer membrane permeability in intact cells was determined by using a high-pressure liquid chromatography (HPLC)-based technique that avoided certain possible artifacts of the traditional methods. Vmax values were calculated from the numbers of enzyme molecules produced per cell and from catalytic constant (Kcat) values, which were obtained with purified beta-lactamase. Minimal periplasmic antibiotic concentrations needed to inhibit bacterial cell wall synthesis were estimated from the Zimmermann-Rosselet equation. All the beta-lactams tested formed relatively stable complexes with purified beta-lactamase. The antibiotics that exhibited low affinity for beta-lactamase apparently needed higher periplasmic concentrations to inhibit cell wall synthesis, suggesting a possible correlation between the affinity of beta-lactamase and the affinity of penicillin-binding proteins for the new beta-lactams. By using these estimates of outer membrane permeability, beta-lactamase hydrolysis, and cell wall-inhibiting concentrations, MIC could be theoretically predicted to within 1 dilution for five beta-lactams in three isogenic E. cloacae strains with differences in antibiotic susceptibility due to different porin or beta-lactamase contents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014984      PMCID: PMC244944          DOI: 10.1128/AAC.35.1.73

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Do beta-lactamases 'trap' cephalosporins?

Authors:  D M Livermore
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

2.  Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants.

Authors:  J Smit; Y Kamio; H Nikaido
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

Review 3.  Penicillin-sensitive enzymes in peptidoglycan biosynthesis.

Authors:  J M Frère; B Joris
Journal:  Crit Rev Microbiol       Date:  1985       Impact factor: 7.624

4.  Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy.

Authors:  D J Phelps; D D Carlton; C A Farrell; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.

Authors:  W Zimmermann; A Rosselet
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

6.  Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.

Authors:  R L Then; P Angehrn
Journal:  Chemioterapia       Date:  1985-02

7.  Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae.

Authors:  V Werner; C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.

Authors:  H Vu; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

9.  Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.

Authors:  K Bush; S K Tanaka; D P Bonner; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.

Authors:  S Kobayashi; S Arai; S Hayashi; K Fujimoto
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

View more
  16 in total

1.  Substitutions in the eyelet region disrupt cefepime diffusion through the Escherichia coli OmpF channel.

Authors:  V Simonet; M Malléa; J M Pagès
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model.

Authors:  D M Cappelletty
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.

Authors:  O Mimoz; A Jacolot; S Leotard; N Hidri; K Samii; P Nordmann; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

4.  Susceptibility to beta-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding protein 3.

Authors:  X Liao; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 5.  The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.

Authors:  S Y Essack
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

6.  Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells.

Authors:  F Bellido; J C Pechère; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

7.  Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.

Authors:  M J Pucci; J Boice-Sowek; R E Kessler; T J Dougherty
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

8.  Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae.

Authors:  G Cornaglia; K Russell; G Satta; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 9.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.

Authors:  M Picard; F Malouin
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.